Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
MedTech
Boston Scientific expands Farapulse afib reach with new approval
In its first year on the market, Farapulse brought in more than $1 billion in revenue. Now, Boston Scientific aims to reach the full afib population.
Conor Hale
Jul 7, 2025 11:58am
FDA clears Fasikl AI stimulation wristwatch for essential tremor
Jul 3, 2025 9:15am
Biotech leaders urge FDA to not restrict abortion pill access
Jul 2, 2025 2:14pm
Vyne prunes psoriasis trial, but keeps faith in BET inhibitor
Jul 2, 2025 10:33am
Siemens Healthineers rolls out helium-sealed 1.5T MRI scanner
Jul 1, 2025 12:00pm
GE HealthCare's PET agent Vizamyl expands reach in Alzheimer's
Jun 27, 2025 9:45am
